Prospera Financial Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Buy |
5,412
+4,168
| +335% | +$1.62M | 0.04% | 453 |
|
|
2025
Q1 | $544K | Buy |
1,244
+11
| +0.9% | +$4.81K | 0.01% | 752 |
|
|
2024
Q4 | $457K | Buy |
1,233
+8
| +0.7% | +$2.97K | 0.01% | 768 |
|
|
2024
Q3 | $640K | Sell |
1,225
-6
| -0.5% | -$3.13K | 0.02% | 636 |
|
|
2024
Q2 | $669K | Buy |
1,231
+9
| +0.7% | +$4.89K | 0.02% | 611 |
|
|
2024
Q1 | $635K | Buy |
1,222
+84
| +7% | +$43.7K | 0.02% | 623 |
|
|
2023
Q4 | $537K | Sell |
1,138
-15
| -1% | -$7.07K | 0.02% | 636 |
|
|
2023
Q3 | $503K | Buy |
1,153
+76
| +7% | +$33.2K | 0.02% | 612 |
|
|
2023
Q2 | $480K | Sell |
1,077
-193
| -15% | -$86.1K | 0.02% | 633 |
|
|
2023
Q1 | $585K | Hold |
1,270
| – | – | 0.02% | 566 |
|
|
2022
Q4 | $652K | Buy |
1,270
+223
| +21% | +$114K | 0.03% | 465 |
|
|
2022
Q3 | $477K | Buy |
1,047
+468
| +81% | +$213K | 0.02% | 534 |
|
|
2022
Q2 | $280K | Buy |
579
+53
| +10% | +$25.6K | 0.01% | 649 |
|
|
2022
Q1 | $259K | Sell |
526
-19
| -3% | -$9.36K | 0.01% | 789 |
|
|
2021
Q4 | $253K | Sell |
545
-582
| -52% | -$270K | 0.01% | 752 |
|
|
2021
Q3 | $420K | Buy |
1,127
+162
| +17% | +$60.4K | 0.02% | 579 |
|
|
2021
Q2 | $369K | Sell |
965
-69
| -7% | -$26.4K | 0.02% | 608 |
|
|
2021
Q1 | $371K | Sell |
1,034
-11
| -1% | -$3.95K | 0.02% | 562 |
|
|
2020
Q4 | $337K | Buy |
1,045
+1,034
| +9,400% | +$333K | 0.02% | 505 |
|
|
2020
Q3 | $3K | Buy |
+11
| New | +$3K | ﹤0.01% | 1376 |
|
|
2018
Q1 | – | Sell |
-1,040
| Closed | -$239K | – | 446 |
|
|
2017
Q4 | $239K | Buy |
+1,040
| New | +$239K | 0.04% | 349 |
|